Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
Rees MI, Harvey K, Pearce BR, Chung SK, Duguid IC, Thomas P, Beatty S, Graham GE, Armstrong L, Shiang R, Abbott KJ, Zuberi SM, Stephenson JB, Owen MJ, Tijssen MA, van den Maagdenberg AM, Smart TG, Supplisson S, Harvey RJ.
???displayArticle.abstract???
Hyperekplexia is a human neurological disorder characterized by an excessive startle response and is typically caused by missense and nonsense mutations in the gene encoding the inhibitory glycine receptor (GlyR) alpha1 subunit (GLRA1). Genetic heterogeneity has been confirmed in rare sporadic cases, with mutations affecting other postsynaptic glycinergic proteins including the GlyR beta subunit (GLRB), gephyrin (GPHN) and RhoGEF collybistin (ARHGEF9). However, many individuals diagnosed with sporadic hyperekplexia do not carry mutations in these genes. Here we show that missense, nonsense and frameshift mutations in SLC6A5 (ref. 8), encoding the presynaptic glycine transporter 2 (GlyT2), also cause hyperekplexia. Individuals with mutations in SLC6A5 present with hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. SLC6A5 mutations result in defective subcellular GlyT2 localization, decreased glycine uptake or both, with selected mutations affecting predicted glycine and Na+ binding sites.
Eulenburg,
Glycine transporters: essential regulators of neurotransmission.
2005, Pubmed
Eulenburg,
Glycine transporters: essential regulators of neurotransmission.
2005,
Pubmed Gabernet,
Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression.
2005,
Pubmed Gomeza,
Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.
2003,
Pubmed Gomeza,
Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.
2003,
Pubmed Hahn,
X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28.
2002,
Pubmed Hahn,
Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation.
2005,
Pubmed Hahn,
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.
2002,
Pubmed Harvey,
The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.
2004,
Pubmed Horiuchi,
Cellular localization and subcellular distribution of Unc-33-like protein 6, a brain-specific protein of the collapsin response mediator protein family that interacts with the neuronal glycine transporter 2.
2005,
Pubmed Horiuchi,
Surface-localized glycine transporters 1 and 2 function as monomeric proteins in Xenopus oocytes.
2001,
Pubmed
,
Xenbase Krogsgaard-Larsen,
GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
2000,
Pubmed Mager,
Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes.
1993,
Pubmed
,
Xenbase Mager,
Ion binding and permeation at the GABA transporter GAT1.
1996,
Pubmed
,
Xenbase Morrow,
Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome.
1998,
Pubmed Ohno,
The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1.
2004,
Pubmed Rees,
Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia.
2001,
Pubmed Rees,
Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).
2002,
Pubmed Rees,
Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia.
2003,
Pubmed Richerson,
Role of the GABA transporter in epilepsy.
2004,
Pubmed Rosenberg,
High prevalence of SLC6A8 deficiency in X-linked mental retardation.
2004,
Pubmed Roux,
The glial and the neuronal glycine transporters differ in their reactivity to sulfhydryl reagents.
2001,
Pubmed
,
Xenbase Roux,
Neuronal and glial glycine transporters have different stoichiometries.
2000,
Pubmed
,
Xenbase Shiang,
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
1993,
Pubmed Shiang,
Mutational analysis of familial and sporadic hyperekplexia.
1995,
Pubmed Supplisson,
Why glycine transporters have different stoichiometries.
2002,
Pubmed Tsai,
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.
2004,
Pubmed Tunnicliff,
Membrane glycine transport proteins.
2003,
Pubmed Vergouwe,
Hyperekplexia-like syndromes without mutations in the GLRA1 gene.
1997,
Pubmed Yamashita,
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
2005,
Pubmed
